ELDERPHARM

Elder Pharmaceuticals Limited has informed the Exchange that the Promoter have appointed Non-Executive Independent Directors i.e. Mr. Ravani Mohammed Abdul Khader and Mr. Kader Mohammed Davawala as Additional Directors w.e.f. January 25, 2016. Further Dr. (Mrs.) Babita Bhatia was appointed as Additional Director on July 15, 2015 who shall hold office up to the date of the next Annual General Meeting or the last date on which the Annual General Meeting should have been held, whichever is earlier. The last date of the Annual General Meeting was December 31, 2015 and the same is delayed. Therefor

Elder Pharmaceuticals Limited has informed the Exchange that Dr. Sailendra Narain as Non -Executive Independent Director has tendered his resignation as Director of the company with effect from October 20, 2015.Further Company would like to thanks to Dr. Sailendra Narain for the assistance and guidance provided by him during his tenure as Director of the company.Company is in process to find right candidate for appointment of Additional Director on the Board to comply with the requirement as per Companies Act, 2013 and corporate Governance norms under clause 49 of listing agreement.

Elder Pharmaceuticals Limited has informed the Exchange that Dr. Joginder Singh Juneja as Non -Executive Independent Director has tendered his resignation as Director of the company with effect from October 21, 2015.Further Company would like to thanks to Dr. Joginder Singh Juneja for the assistance and guidance provided by him during his tenure as Director of the company.Company is in process to find right candidate for appointment of Additional Director on the Board to comply with the requirement as per Companies Act, 2013 and corporate Governance norms under clause 49 of listing agreement.

Elder Pharmaceuticals Limited has informed the Exchange that Mr. Bimal Desai, Chief Financial Officer of the Company has resigned w.e.f. August 31, 2015.Management has accepted his resignation and he has been relived from the services of the Company.

Elder Pharmaceuticals Limited has informed the Exchange that Mr. Saleem Shervni, Non-Executive-Independent Director of the Company has tendered his resignation as Non-Executive-Independent Director Of the Company with effect from December 11, 2014.

Elder Pharmaceuticals Limited has informed the Exchange that as per the Listing Agreement and Section 203 of the Companies Act 2013 read with the Companies (Appointment Remuneration of Managerial Personnel) Rules, 2014, Mr. Bimal Desai is been appointed as Chief Financial Officer (CFO) of the Company w.e.f. December 01, 2014.

Elder Pharmaceuticals Limited has informed the Exchange that Dr. Jayaram Subramanian Non-Executive Independent Director of the Company has tendered his resignation as Non-Executive Independent Director of the Company with effect from December 01, 2014.

Elder Pharmaceuticals Limited has informed the Exchange that Mrs. Urvashi Saxena, Non-Executive Independent Director has tendered her resignation as Director of the company with effect from November 28, 2OI4. Further Company would like to thanks to Mrs. Urvashi Saxena for the assistance and guidance provided by her during her tenure as Director of the company.

Elder Pharmaceuticals Limited has informed the Exchange that at the meeting of the Board of Directors of the Company held on November 14, 2014: 1. The Board accepted the resignation of Mr. Farid R Gulmohamed, Additional Director of the Company w.e.f. November 14, 2014; 2. The Board accepted the resignation of Mr. Yusuf Karim Khan, Executive Director of the Company w.e.f. November 12, 2014; 3. The Board accepted the resignation of Mr. Suresh Pai, Chief Financial Officer of the Company who will be resigning w.e.f. November 30, 2014.

Elder Pharmaceuticals Limited has informed the Exchange that Mr Michael Bastian, Non-Executive Directors has tendered his resignation as Director of the company with effect from August 09, 2014. Further Company would like to thanks to Mr Michael Bastian for the assistance and guidance provided by him during his tenure as Director of the Company.

Elder Pharmaceuticals Limited has informed the Exchange that Dr J.S. Juneja, Non- executive- independent Director of the Company has tendered his resignation as Non- Executive Chairman of the Company with effect from August 01, 2014. However he will continue to serve on the Board as Non-executive independent Director of the Company.

Elder Pharmaceuticals Limited has informed the Exchange that Dr. Raghavachari Srinivasan, Director of the Company has resigned from the Board of the Company w.e.f. June 05, 2014.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 09, 2012 have re-appoint Mr. Yusuf Karim Khan as Executive Director for a period of five years w.e.f. August 28, 2012, subject to approval of the shareholders at the ensuing Annual General Meeting and appropriate authorities, if any.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors at their meeting held on July 27, 2010 have decided to accept the resignation of Mr. M.V. Thomas as Director with effect from July 01, 2010.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on July 27, 2010 decided to accept the resignation of Mr. M. V. Thomas as Director with effect from July 01, 2010.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 05, 2010, on recommendation of the Audit Committee appointed Mr. M V Thomas, Director (Finance) of the Company as CFO.

Elder Pharmaceuticals Limited has informed the Exchange that at the Board Meeting of the Company held on July 24, 2007, the Board decided to accept the resignation of Mr. V.N. Paranjpe as Joint Managing Director. The Board also decided to raise funds through ECB and/or issuance of FCCBs upto an amount of 50 Million US dollars for acquisition opportunities/capex and authorized the Managing Director to take necessary steps and actions thereon including convening of Extra Ordinary General Meeting.

Elder Pharmaceuticals Limited has informed the Exchange that a meeting of the Board of Directors of the Company was held on September 29,2006. It was decided at the said meeting to appoint Mr. Michael Bastian as an Additional Director on the Board from September 29,2006.